2010
DOI: 10.1016/j.tiv.2009.09.014
|View full text |Cite
|
Sign up to set email alerts
|

In vitro mammalian cytotoxicological study of PAMAM dendrimers – Towards quantitative structure activity relationships

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

10
117
0

Year Published

2013
2013
2024
2024

Publication Types

Select...
5
1

Relationship

2
4

Authors

Journals

citations
Cited by 137 publications
(127 citation statements)
references
References 40 publications
10
117
0
Order By: Relevance
“…The lower initial value of 170 the PAMAM G6 dendrimers was used due to their reported EC 50 value being much lower than 171 their G4 counterparts. 7,8,9 Dose dependent viability percentages were calculated at time points: 6, 172 12, 24, 48 and 72 hours. Percentage viability was calculated as compared to a control which had 173 been exposed to 200μM BSO, but had no nanoparticle treatment; this was to ensure any changes 174 were caused by the nanoparticle and were not the result of BSO treatment.…”
Section: Viability Assays 165mentioning
confidence: 99%
See 4 more Smart Citations
“…The lower initial value of 170 the PAMAM G6 dendrimers was used due to their reported EC 50 value being much lower than 171 their G4 counterparts. 7,8,9 Dose dependent viability percentages were calculated at time points: 6, 172 12, 24, 48 and 72 hours. Percentage viability was calculated as compared to a control which had 173 been exposed to 200μM BSO, but had no nanoparticle treatment; this was to ensure any changes 174 were caused by the nanoparticle and were not the result of BSO treatment.…”
Section: Viability Assays 165mentioning
confidence: 99%
“…The MTT results show a dramatically different dose dependent cytotoxicity 330 profile for the BSO dosed cells compared to un-dosed. 7 At 6 hours exposure (Figure 4b), the 331 viability is seen to be reduced to around 80% over the entire dose range. However, at exposure 332 times of 12, 24, 48 and 72 hours, increases in viability are seen for the low-medium dose range.…”
mentioning
confidence: 97%
See 3 more Smart Citations